Central corneal thickness in patients with neovascular age-related macular degeneration

George D. Kymionis, Theoni D. Panagiotoglou, Sonia H. Yoo, Nikolaos S. Tsiklis, Emmanouel Christodoulakis, George C. Hajithanasis, Miltiadis K. Tsilimbaris, Ioannis G. Pallikaris

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

PURPOSE: To compare the central corneal thickness (CCT) measurements of patients with neovascular age-related macular degeneration (AMD) and control subjects. METHODS: The CCT value (measured with ultrasound corneal pachymetry) of 130 eyes (130 patients, 1 eye from each patient) with neovascular AMD (AMD group) and 98 eyes (98 patients, 1 eye from each patient) of similar age, sex, and eye's axial length healthy control subjects (normal group) was compared. RESULTS: The mean age (AMD group: 69.1 years vs. control group: 69.5 years, P = 0.81), sex (AMD group: 77 women, 59% vs. control group: 59 women, 60%, P = 0.77), and eye's axial length (AMD group: 25.05-mm vs. control group: 24.61-mm, P = 0.38) of patients with neovascular AMD and healthy control subjects were comparable. There were no statistically significant differences in the mean CCT measurements in the neovascular AMD group in comparison with the control group (549.44 vs. 544.35 μm, P = 0.11). CONCLUSIONS: CCT measurements do not differ in patients with neovascular AMD compared with healthy control subjects.

Original languageEnglish (US)
Pages (from-to)182-184
Number of pages3
JournalCornea
Volume26
Issue number2
DOIs
StatePublished - Feb 1 2007

Keywords

  • Age-related macular degeneration
  • Corneal thickness
  • Neovascular

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Central corneal thickness in patients with neovascular age-related macular degeneration'. Together they form a unique fingerprint.

Cite this